Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study-Reference-Cited by-同舟云学术

Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study

Published:2021-05 Issue: Volume:148 Page:359-370
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ladoire Sylvain^ORCID,Goussot Vincent^ORCID,Redersdorff Emilie,Cueff Adele,Ballot Elise,Truntzer Caroline^ORCID,Ayati Siavoshe,Bengrine-Lefevre Leila,Bremaud Nathalie,Coudert Bruno^ORCID,Desmoulins Isabelle,Favier Laure,Fraisse Cléa^ORCID,Fumet Jean-David^ORCID,Hanu Roxana,Hennequin Audrey,Hervieu Alice,Ilie Silvia,Kaderbhai Courèche,Lagrange Aurélie,Martin Nils,Mazilu Irina,Mayeur Didier,Palmier Rémi,Simonet-Lamm Anne-Laure,Vincent Julie,Zanetta Sylvie^ORCID,Arnould Laurent,Coutant Charles,Bertaut Aurélie,Ghiringhelli François

Funder

Roche

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

2. Global transmission network of SARS-CoV-2: from outbreak to pandemic;Skums;medRxiv,2020

3. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

4. info coronavirus covid 19 - carte et donnees covid 19 en france. Gouvernement.fr https://www.gouvernement.fr/info-coronavirus/carte-et-donnees.

5. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China;Yu;JAMA Oncol,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study;International Journal of Environmental Research and Public Health;2023-05-25

2. Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis;Chemical Senses;2023-01-01

3. Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 (“Omicron”) SARS-CoV-2 Variant Wave;Cancers;2022-09-23

4. SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis;European Journal of Medical Research;2022-06-02

5. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study;European Journal of Cancer;2022-04